NUR2474 / NUR 2474 Module 1 Quiz Review
(Latest ): Pharmacology for Professional
Nursing - Rasmussen
Questions and Verified Answers | 100% Correct | Grade A Study Resource
90 7 A-D 2026/2027
SINGLE-BEST-ANSWER LATEST UPDATE
TOTAL QUESTIONS COURSE SECTIONS
MCQ ALIGNMENT
Content focus: foundational pharmacology competencies aligned with Rasmussen University NUR 2474 Module 1 objectives,
including drug regulation and legislation, pharmacokinetics, pharmacodynamics, the six rights and three checks, dosage
calculations with step-by-step rationales, lifespan and cultural considerations, pharmacogenomics, and patient education.
Cognitive mix: 35% recall / 45% application / 20% analysis. Style mix: 70% scenario-based items and 30% direct recall and
calculation items. Distractors represent common foundational pharmacology student errors.
SECTION 1: FOUNDATIONS OF PHARMACOLOGY AND DRUG
Questions 1-12
REGULATION
Drug sources - Drug names (chemical, generic, brand) - FDA approval phases - Pregnancy categories - Drug legislation - Controlled
substance schedules and DEA requirements
Q1: A nursing student learns that digoxin, a cardiac glycoside used to treat heart failure and atrial fibrillation,
was originally derived from the foxglove plant (Digitalis purpurea). Which classification BEST describes this
drug source?
A. Mineral-based source
B. Plant-based (botanical) source [CORRECT]
C. Animal-based (biologic) source
D. Synthetic laboratory source
Correct Answer: B
Rationale: Digoxin is the classic example of a plant-derived drug, extracted from the leaves of the foxglove
plant. Minerals (iron, iodine), animal products (insulin, heparin), and synthetic laboratory compounds form the
other major source categories, so misidentifying the origin confuses basic pharmacognosy. Exam tip: link classic
drugs to their sources (digoxin-foxglove, insulin-animal pancreas, iron-mineral).
1
,NUR2474 / NUR 2474 Module 1 Quiz Review (Latest ) Rasmussen University | Pharmacology for Professional Nursing
Q2: During orientation, a preceptor holds up a drug label and asks a new nurse to identify the official
nonproprietary name, which is not owned by any manufacturer and is written in lowercase letters (for example,
acetaminophen). The preceptor is describing the:
A. Brand (trade) name
B. Chemical name
C. Proprietary name
D. Generic name [CORRECT]
Correct Answer: D
Rationale: The generic name identifies the active ingredient regardless of manufacturer and is never
trademarked, whereas the brand, trade, or proprietary name is capitalized and company-owned (acetaminophen
versus Tylenol). The chemical name describes the drug's exact molecular structure. Confusing generic with trade
names causes duplicate-therapy errors when patients take two products containing the same active ingredient.
Q3: A patient newly prescribed levothyroxine tells the nurse, 'The pharmacist gave me the generic instead of
Synthroid. Does that mean I received a weaker drug?' Which response by the nurse is MOST accurate?
A. Generic products contain the same active ingredient and must demonstrate bioequivalence to the
brand-name product [CORRECT]
B. Generic products contain a smaller amount of the active ingredient than the brand-name product
C. Generic products are chemically different compounds that produce the same therapeutic effect
D. Generic products are appropriate only for patients who cannot afford brand-name prescriptions
Correct Answer: A
Rationale: FDA-approved generics must contain the identical active ingredient and demonstrate bioequivalence,
meaning a similar rate and extent of absorption compared with the reference brand. Responses implying that
generics are weaker, chemically different, or inferior misrepresent the FDA bioequivalence standard. For
narrow-range drugs such as levothyroxine, patients should ideally stay with one formulation consistently.
Q4: During which phase of the FDA new drug approval process is an investigational drug first administered to a
small group (20 to 100) of healthy volunteers to evaluate safety, dosage range, and pharmacokinetics?
A. Phase II
B. Phase III
C. Phase IV
D. Phase I [CORRECT]
Correct Answer: D
Rationale: Phase I trials enroll small numbers of healthy volunteers and focus on safety, tolerability, and
pharmacokinetics in humans for the first time. Phase II enrolls patients who have the target disease to assess
effectiveness, Phase III uses large patient populations to confirm efficacy and monitor adverse effects, and Phase
IV occurs after marketing approval. Remember the progression: healthy volunteers, small patient trials, large
trials, then the open market.
2
,NUR2474 / NUR 2474 Module 1 Quiz Review (Latest ) Rasmussen University | Pharmacology for Professional Nursing
Q5: A drug has received FDA approval and is now prescribed widely across the country. The manufacturer
continues collecting and submitting reports of rare adverse effects that appear only after long-term use in very
large populations. The nurse recognizes that this surveillance activity occurs during which phase?
A. Phase I
B. Phase IV (post-marketing surveillance) [CORRECT]
C. Preclinical testing
D. New Drug Application (NDA) review
Correct Answer: B
Rationale: Phase IV begins after FDA approval and involves ongoing surveillance of thousands of patients,
which can detect rare or long-term adverse effects that earlier smaller trials were not powered to find. Preclinical
testing occurs before any human exposure, and Phases I through III are completed before approval. This ongoing
surveillance is why drugs are occasionally withdrawn or relabeled years after release.
Q6: A nursing student is reviewing the former FDA pregnancy risk categories with a study group. Which
statement accurately describes Pregnancy Category X?
A. Well-controlled human studies have failed to demonstrate a risk to the fetus
B. Animal studies have shown no fetal risk, but no adequate human studies are available
C. Studies in humans or animals have demonstrated fetal abnormalities, and the risk of use in pregnant
women clearly outweighs any possible benefit [CORRECT]
D. The drug may be used during pregnancy only if the potential benefits justify the potential fetal risk
Correct Answer: C
Rationale: Category X drugs such as isotretinoin and thalidomide are absolutely contraindicated in pregnancy
because proven fetal harm outweighs any benefit. The second option describes Category A, the third resembles
Category B, and the fourth describes Category D. Distinguishing these definitions is essential because exam
items frequently present a scenario and ask which category applies.
Q7: A 19-year-old patient with severe acne is prescribed isotretinoin, and the nurse reviews the medication
record. The patient states that she may be pregnant. Which action should the nurse take FIRST?
A. Administer the medication as ordered because isotretinoin is safe in early pregnancy
B. Hold the medication and immediately notify the prescriber of the possible pregnancy [CORRECT]
C. Advise the patient to simply use a reliable birth control method while taking the drug
D. Ask the patient to return next month for a pregnancy test before taking any further doses
Correct Answer: B
Rationale: Isotretinoin is a Pregnancy Category X teratogen, so when pregnancy is possible the nurse must hold
the dose and notify the prescriber immediately for an alternate plan; the iPLEDGE program mandates pregnancy
testing and dual contraception. Administering the drug or merely delaying evaluation exposes the fetus to proven
teratogenic risk. Note that the FDA has since replaced letter categories with the Pregnancy and Lactation
Labeling Rule, but the legacy categories remain heavily tested.
3
, NUR2474 / NUR 2474 Module 1 Quiz Review (Latest ) Rasmussen University | Pharmacology for Professional Nursing
Q8: Which drug legislation, enacted in 1906, was the first United States federal law to regulate medications by
establishing official drug standards (USP) and requiring accurate labeling of drug products?
A. Pure Food and Drug Act [CORRECT]
B. Federal Food, Drug, and Cosmetic Act
C. Controlled Substances Act
D. Kefauver-Harris Amendment
Correct Answer: A
Rationale: The Pure Food and Drug Act of 1906 prohibited misbranding and adulteration and set official
labeling standards, but it did not require drugs to be proven safe or effective. The FDCA of 1938 added the
premarket safety requirement, the Kefauver-Harris Amendment of 1962 added the efficacy requirement, and the
Controlled Substances Act of 1970 created the abuse-potential scheduling system. Knowing what each law did
NOT require is the classic distractor trap on legislation questions.
Q9: In 1937, more than 100 people died after taking an elixir of sulfanilamide dissolved in a toxic solvent that
had never been tested for human safety. Which federal law resulted directly from this tragedy and first required
manufacturers to prove a drug's safety before marketing it?
A. Pure Food and Drug Act of 1906
B. Durham-Humphrey Amendment of 1951
C. Federal Food, Drug, and Cosmetic Act of 1938 [CORRECT]
D. Controlled Substances Act of 1970
Correct Answer: C
Rationale: The elixir sulfanilamide disaster directly prompted the FDCA of 1938, which mandated premarket
proof of safety and strengthened FDA authority over drug approval. The 1906 act required only truthful labeling
and could not have prevented the disaster; Durham-Humphrey later distinguished prescription from
over-the-counter drugs; and the Controlled Substances Act addressed abuse potential rather than safety testing.
Analyzing which law answers which historical failure is a common analysis-level item.
Q10: Which federal legislation, enacted in 1970, established the five controlled substance schedules (I through
V) and designated the Drug Enforcement Administration to enforce controlled substance regulations?
A. Pure Food and Drug Act
B. Controlled Substances Act [CORRECT]
C. Federal Food, Drug, and Cosmetic Act
D. Durham-Humphrey Amendment
Correct Answer: B
Rationale: The Controlled Substances Act of 1970 classified drugs into Schedules I through V according to
abuse potential and accepted medical use and created DEA enforcement and registration requirements for
prescribers and dispensers. The other laws address labeling, premarket safety, or prescription status rather than
abuse scheduling. DEA registration is renewed every three years and is required before a prescriber may write
controlled substance prescriptions.
4